For the quarterly period ended JUNE 30, 2021 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Commission File Number: 001-37685 PAVmed Inc. OR (Exact Name of Registrant as Specified in Its Charter) ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Delaware 47-1214177 (State or Other Jurisdiction of Incorporation or Organization) For the ...

PAVmed Inc. (NASDAQ:PAVM) Q2 2021 Earnings Conference Call August 12, 2021 4:30 PM ET Company Participants Mike Havrilla - Director of IR Lishan Aklog - Chairman and CEO Dennis McGrath - President and CFO Conference Call Participants Frank Takkinen - Lake Street Capital Ed Woo - Ascendiant Capital Markets Jeremy Pearlman - Maxim Group Operator Greetings, and welcome to the PAVmed Inc. Business Update Conference call. At this time, all participants are in a listen-only mode. A question-and-answer session wil ...

PAVmed Inc. (NASDAQ:PAVM) Q1 2021 Earnings Conference Call May 17, 2021 4:30 PM ET Company Participants Mike Havrilla - Director of Investor Relations Lishan Aklog - Chairman & Chief Executive Officer Dennis McGrath - President & Chief Financial Officer Conference Call Participants Kyle Mikson - Cantor Fitzgerald Frank Takkinen - Lake Street Capital Markets Anthony Vendetti - Maxim Group Ed Woo - Ascendiant Capital Frank Ibarra - IbarMax, LLC Operator Greetings, and welcome to the PAVmed Inc. Business Updat ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended MARCH 31, 2021 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from______ to______ Commission File Number: 001-37685 PAVmed Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 47-1214177 (State or Other Juri ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-K (Mark One) [X] ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the fiscal year ended December 31, 2020 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from _____ to _____ Commission File Number: 001-37685 PAVMED INC. (Exact Name of Registrant as Specified in Its Charter) Delaware 47-1214177 (State or Other Jurisdict ...

PAVmed Inc. (NASDAQ:PAVM) Business Update and Preliminary Q4 2020 Conference Call February 22, 2021 8:30 AM ET Company Participants Mike Havrilla – Director-Investor Relations Lishan Aklog – Chairman and Chief Executive Officer Dennis McGrath – President and Chief Financial Officer Stanley Lapidus – Strategic Advisor-Lucid Diagnostics Conference Call Participants Frank Takkinen – Lake Street Capital Markets Anthony Vendetti – Maxim Group Ed Woo – Ascendiant Capital Operator Greetings, and welcome to PAVmed ...

PAVmed, Inc. (NASDAQ:PAVM) Q3 2020 Earnings Conference Call November 17, 2020 4:30 PM ET Company Participants Mike Havrilla – Director-Investor Relations Lishan Aklog – Chairman and Chief Executive Officer Dennis McGrath – President and Chief Financial Officer Conference Call Participants Frank Takkinen – Lake Street Capital Markets Anthony Vendetti – Maxim Group Ed Woo – Ascendiant Capital Operator Greetings, and welcome to the PAVmed, Inc. Business Update Conference Call. [Operator Instructions] As a remi ...

UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 10-Q (Mark One) [X] QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended SEPTEMBER 30, 2020 OR [ ] TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from______ to______ Commission File Number: 001-37685 PAVmed Inc. (Exact Name of Registrant as Specified in Its Charter) Delaware 47-1214177 (State or Other ...

彩PAVmed THCARE CONFERENCE Corporate Overview LISHAN AKLOG, MD Chairman & CEO September 15, 2020 Nasdaq: PAVM, PAVMZ Disclaimers This presentation contains certain forward-looking statements that involve risks and uncertainties. • Actual results and events may differ significantly from results and events discussed in forward-looking statements. • Factors that might cause or contribute to such differences include, but are not limited to, those discussed in "Risk Factors" in our Annual Report on Form 10-K and ...

PAVmed Inc. (NASDAQ:PAVM) Q2 2020 Earnings Conference Call August 18, 2020 4:30 PM ET Company Participants Mike Havrilla - Director of Investor Relations Lishan Aklog - Chairman and Chief Executive Officer Dennis McGrath - President and Chief Financial Officer Conference Call Participants Anthony Vendetti - Maxim Group Operator Greetings and welcome to the PAVmed Incorporated Business Update Conference Call. At this time, all participants are in a listen-only mode. A question-and-answer session will follow ...